ENTA — Enanta Pharmaceuticals, Inc. | XLV Holdings | StockAdder

(ENTA)

Enanta Pharmaceuticals, Inc.

Live chart and latest ENTA stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

ENTA News

What Makes Enanta Pharmaceuticals (ENTA) a New Buy Stock

Feb 12, 2026 simplywall.st

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Dec 20, 2025 Stock Titan

Vanguard disaggregates holdings; reports 0 shares of Enanta (ENTA)

Mar 26, 2026 Stocktwits

Enanta Pharmaceuticals Stock Rises 58% – Here’s An Important Update

Sep 29, 2025 BioSpace

Enanta Pharmaceuticals Announces Proposed Public Offering of Common Stock

Oct 1, 2025 Seeking Alpha

Enanta: Maintaining Buy Rating Based On Zelicapavir Potential In RSV Development (ENTA)

Nov 19, 2025 Yahoo Finance

Wall Street Analysts Believe Enanta Pharmaceuticals (ENTA) Could Rally 44.85%: Here's is How to Trade

Nov 21, 2025 Stock Titan

Enanta (ENTA) director Lesley Russell receives stock options on 20,000 shares

Mar 13, 2026 Benzinga

Cal-Maine Foods Posts Downbeat Earnings, Joins Enanta Pharmaceuticals, AAR And Other Big Stocks Moving Lo

Oct 1, 2025 CNN

symbol__ Stock Quote Price and Forecast

Mar 14, 2024 simplywall.st

Enanta Pharmaceuticals (ENTA) Is Up 33.3% After Positive Phase 2b RSV Results Propel Zelicapavir Forward

Oct 3, 2025 Stock Titan

Enanta (ENTA) director awarded stock option for 20,000 shares

Mar 13, 2026 Zacks Investment Research

What is the current Price Target and Forecast for Enanta Pharmaceuticals (ENTA)

Aug 30, 2022 TradingView — Track All Markets

ENTA Forecast — Price Target — Prediction for 2027

Aug 28, 2022 Seeking Alpha

Enanta: Despite Primary Endpoint Miss Zelicapavir Could Benefit From Trial Design Change